MARTINA BEST: Open Payments
NPI 1760050181 · RANSON, WV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$914 in 41 payments from 9 companies in 2025. Trend: 2023 $532 · 2024 $884 · 2025 $914
Food & beverage: $869Education: $45
| Company | Payments | Amount |
|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. | 10 | $224 |
| AstraZeneca Pharmaceuticals LP | 8 | $172 |
| Novo Nordisk Inc | 6 | $139 |
| Lilly USA, LLC | 6 | $135 |
| PFIZER INC. | 3 | $76 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $50 |
| Exact Sciences Corporation | 2 | $47 |
| GlaxoSmithKline, LLC. | 2 | $42 |
| Kowa Pharmaceuticals America, Inc. | 2 | $31 |
Products named: Kerendia, Ozempic, AIRSUPRA, MOUNJARO, PREVNAR 20, FARXIGA, CAPLYTA, TRELEGY ELLIPTA.
Industry payments across WV — which companies pay providers there.
